-
1
-
-
60349092901
-
Myelodysplastic syndromes: biology and treatment
-
Jädersten M., Hellström-Lindberg E. Myelodysplastic syndromes: biology and treatment. J Intern Med 2009, 265:307-328.
-
(2009)
J Intern Med
, vol.265
, pp. 307-328
-
-
Jädersten, M.1
Hellström-Lindberg, E.2
-
2
-
-
47149109822
-
MicroRNAs in normal and malignant hematopoiesis
-
Garzon R., Croce C.M. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008, 15:352-358.
-
(2008)
Curr Opin Hematol
, vol.15
, pp. 352-358
-
-
Garzon, R.1
Croce, C.M.2
-
3
-
-
58149145653
-
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
-
Bousquet M., Quelen C., Rosati R., Mansat-De Mas V., La Starza R., Bastard C., et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008, 205:2499-2506.
-
(2008)
J Exp Med
, vol.205
, pp. 2499-2506
-
-
Bousquet, M.1
Quelen, C.2
Rosati, R.3
Mansat-De Mas, V.4
La Starza, R.5
Bastard, C.6
-
4
-
-
42449141513
-
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
-
Garzon R., Volinia S., Liu C.G., Fernandez-Cymering C., Palumbo T., Pichiorri F., et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008, 111:3183-3189.
-
(2008)
Blood
, vol.111
, pp. 3183-3189
-
-
Garzon, R.1
Volinia, S.2
Liu, C.G.3
Fernandez-Cymering, C.4
Palumbo, T.5
Pichiorri, F.6
-
5
-
-
73849121794
-
Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype
-
Starczynowski D.T., Kuchenbauer F., Argiropoulos B., Sung S., Morin R., Muranyi A., et al. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med 2010, 16:49-58.
-
(2010)
Nat Med
, vol.16
, pp. 49-58
-
-
Starczynowski, D.T.1
Kuchenbauer, F.2
Argiropoulos, B.3
Sung, S.4
Morin, R.5
Muranyi, A.6
-
6
-
-
35748956094
-
Gene expression profiling of CD34+ cells in patients with the 5q-syndrome
-
Boultwood J., Pellagatti A., Cattan H., Lawrie C.H., Giagounidis A., Malcovati L., et al. Gene expression profiling of CD34+ cells in patients with the 5q-syndrome. Br J Haematol 2007, 139:578-589.
-
(2007)
Br J Haematol
, vol.139
, pp. 578-589
-
-
Boultwood, J.1
Pellagatti, A.2
Cattan, H.3
Lawrie, C.H.4
Giagounidis, A.5
Malcovati, L.6
-
7
-
-
0002789260
-
Classical and molecular cytogenetics of tumor cells
-
Springer-Press, New York, R. Wegener (Ed.)
-
Schlegelberger B., Metzke S., Harder S., Zulke-Jenisch R., Zhang Y., Siebert R. Classical and molecular cytogenetics of tumor cells. Cytogenetics 1999, 151-185. Springer-Press, New York. R. Wegener (Ed.).
-
(1999)
Cytogenetics
, pp. 151-185
-
-
Schlegelberger, B.1
Metzke, S.2
Harder, S.3
Zulke-Jenisch, R.4
Zhang, Y.5
Siebert, R.6
-
8
-
-
70349413196
-
Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies
-
Hussein K., von Neuhoff N., Büsche G., Buhr T., Kreipe H., Bock O. Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies. Ann Hematol 2009, 88:1059-1067.
-
(2009)
Ann Hematol
, vol.88
, pp. 1059-1067
-
-
Hussein, K.1
von Neuhoff, N.2
Büsche, G.3
Buhr, T.4
Kreipe, H.5
Bock, O.6
-
9
-
-
60749086311
-
Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm
-
Hussein K., Dralle W., Theophile K., Kreipe H., Bock O. Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm. Ann Hematol 2009, 88:325-332.
-
(2009)
Ann Hematol
, vol.88
, pp. 325-332
-
-
Hussein, K.1
Dralle, W.2
Theophile, K.3
Kreipe, H.4
Bock, O.5
-
10
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
-
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
11
-
-
35448977195
-
MicroRNA expression profile in granulocytes from primary myelofibrosis patients
-
Guglielmelli P., Tozzi L., Pancrazzi A., Bogani C., Antonioli E., Ponziani V., et al. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol 2007, 35:1708-1718.
-
(2007)
Exp Hematol
, vol.35
, pp. 1708-1718
-
-
Guglielmelli, P.1
Tozzi, L.2
Pancrazzi, A.3
Bogani, C.4
Antonioli, E.5
Ponziani, V.6
-
12
-
-
36348963610
-
MicroRNA losses in the frequently deleted region of 7q in SMZL
-
Ruiz-Ballesteros E., Mollejo M., Mateo M., Algara P., Martínez P., Piris M.A. MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 2007, 21:2547-2549.
-
(2007)
Leukemia
, vol.21
, pp. 2547-2549
-
-
Ruiz-Ballesteros, E.1
Mollejo, M.2
Mateo, M.3
Algara, P.4
Martínez, P.5
Piris, M.A.6
-
13
-
-
45149108788
-
MicroRNA expression profiles of human leukemias
-
Takada S., Yamashita Y., Berezikov E., Hatanaka H., Fujiwara S.I., Kurashina K., et al. MicroRNA expression profiles of human leukemias. Leukemia 2008, 22:1274-1278.
-
(2008)
Leukemia
, vol.22
, pp. 1274-1278
-
-
Takada, S.1
Yamashita, Y.2
Berezikov, E.3
Hatanaka, H.4
Fujiwara, S.I.5
Kurashina, K.6
-
14
-
-
55549103713
-
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study
-
Marcucci G., Maharry K., Radmacher M.D., Mrózek K., Vukosavljevic T., Paschka P., et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 2008, 26:5078-5087.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5078-5087
-
-
Marcucci, G.1
Maharry, K.2
Radmacher, M.D.3
Mrózek, K.4
Vukosavljevic, T.5
Paschka, P.6
-
15
-
-
47749117212
-
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia
-
Dixon-McIver A., East P., Mein C.A., Cazier J.B., Molloy G., Chaplin T., et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008, 3:e2141.
-
(2008)
PLoS ONE
, vol.3
-
-
Dixon-McIver, A.1
East, P.2
Mein, C.A.3
Cazier, J.B.4
Molloy, G.5
Chaplin, T.6
-
16
-
-
35748979703
-
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein
-
Fazi F., Racanicchi S., Zardo G., Starnes L.M., Mancini M., Travaglini L., et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007, 12:457-466.
-
(2007)
Cancer Cell
, vol.12
, pp. 457-466
-
-
Fazi, F.1
Racanicchi, S.2
Zardo, G.3
Starnes, L.M.4
Mancini, M.5
Travaglini, L.6
-
17
-
-
77649185483
-
Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome
-
Hussein K., Theophile K., Büsche G., Schlegelberger B., Göhring G., Kreipe H., et al. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res 2010, 34:328-334.
-
(2010)
Leuk Res
, vol.34
, pp. 328-334
-
-
Hussein, K.1
Theophile, K.2
Büsche, G.3
Schlegelberger, B.4
Göhring, G.5
Kreipe, H.6
-
18
-
-
71049175699
-
Hematopoiesis-related microRNA expression in myelodysplastic syndromes
-
Pons A., Nomdedeu B., Navarro A., Gaya A., Gel B., Diaz T., et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 2009, 50:1854-1859.
-
(2009)
Leuk Lymphoma
, vol.50
, pp. 1854-1859
-
-
Pons, A.1
Nomdedeu, B.2
Navarro, A.3
Gaya, A.4
Gel, B.5
Diaz, T.6
-
19
-
-
38349088899
-
Identification of RPS14 as a 5q-syndrome gene by RNA interference screen
-
Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
-
(2008)
Nature
, vol.451
, pp. 335-339
-
-
Ebert, B.L.1
Pretz, J.2
Bosco, J.3
Chang, C.Y.4
Tamayo, P.5
Galili, N.6
-
20
-
-
34547092452
-
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders
-
Joslin J.M., Fernald A.A., Tennant T.R., Davis E.M., Kogan S.C., Anastasi J., et al. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 2007, 110:719-726.
-
(2007)
Blood
, vol.110
, pp. 719-726
-
-
Joslin, J.M.1
Fernald, A.A.2
Tennant, T.R.3
Davis, E.M.4
Kogan, S.C.5
Anastasi, J.6
-
21
-
-
34547474047
-
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients
-
Pellagatti A., Jädersten M., Forsblom A.M., Cattan H., Christensson B., Emanuelsson E.K., et al. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients. Proc Natl Acad Sci USA 2007, 104:11406-11411.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 11406-11411
-
-
Pellagatti, A.1
Jädersten, M.2
Forsblom, A.M.3
Cattan, H.4
Christensson, B.5
Emanuelsson, E.K.6
-
22
-
-
74249103042
-
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
-
Gefen N., Binder V., Zaliova M., Linka Y., Morrow M., Novosel A., et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010, 24:89-96.
-
(2010)
Leukemia
, vol.24
, pp. 89-96
-
-
Gefen, N.1
Binder, V.2
Zaliova, M.3
Linka, Y.4
Morrow, M.5
Novosel, A.6
-
23
-
-
67649848124
-
Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a
-
Slezak S., Jin P., Caruccio L., Ren J., Bennett M., Zia N., et al. Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a. J Transl Med 2009, 7:39.
-
(2009)
J Transl Med
, vol.7
, pp. 39
-
-
Slezak, S.1
Jin, P.2
Caruccio, L.3
Ren, J.4
Bennett, M.5
Zia, N.6
-
24
-
-
41149130219
-
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder
-
O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008, 205:585-594.
-
(2008)
J Exp Med
, vol.205
, pp. 585-594
-
-
O'Connell, R.M.1
Rao, D.S.2
Chaudhuri, A.A.3
Boldin, M.P.4
Taganov, K.D.5
Nicoll, J.6
|